K. Greene

发表

Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs

J. Weiner, D. Montefiori, C. Labranche, 2020, Journal of immunological methods.

Distinguishing features of long COVID identified through immune profiling

C. D. Dela Cruz, D. van Dijk, R. Medzhitov, 2022, Nature.

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Allan C. deCamp, Jerome H. Kim, D. Montefiori, 2017, PloS one.

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection

Lynn Morris, Bette Korber, Tanmoy Bhattacharya, 2016, PLoS pathogens.

Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features

Karen G. Dowell, J. C. Love, C. Bailey-Kellogg, 2021, Retrovirology.

Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa

Feng Gao, Lynn Morris, Cynthia A. Derdeyn, 2006, Journal of Virology.

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

Jerome H. Kim, B. Korber, P. Hraber, 2016, PLoS pathogens.

Impact of Clade, Geography, and Age of the Epidemic on HIV-1 Neutralization by Antibodies

Jerome H. Kim, A. Lapedes, B. Korber, 2014, Journal of Virology.

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies

Allan C. deCamp, B. Haynes, D. Montefiori, 2021, Journal of virology.

Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes

Bette Korber, Hongmei Gao, John R. Mascola, 2014, Journal of Virology.

Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

Raphael Gottardo, S. Gnanakaran, Hongmei Gao, 2013, PloS one.

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies

Ming Li, Feng Gao, Amit Kumar, 2010, PLoS Comput. Biol..

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

Hongmei Gao, Marcella Sarzotti-Kelsoe, Daniel A Ozaki, 2014, Journal of immunological methods.

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models

Ben Murrell, Lynn Morris, Hongmei Gao, 2013, Virology Journal.

Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection.

D. Montefiori, C. Orkin, H. Gao, 2010, The Journal of general virology.

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

Jerome H. Kim, B. Korber, B. Haynes, 2012, AIDS research and human retroviruses.

Vaccination induces HIV broadly neutralizing antibody precursors in humans

Allan C. deCamp, Jordan R. Willis, D. Montefiori, 2022, Science.

Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Xiping Wei, Feng Gao, John R. Mascola, 2005, Journal of Virology.

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

Karen G. Dowell, J. C. Love, J. Kappes, 2016, The Journal of Immunology.

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

T. Kepler, M. Borgnia, B. Korber, 2019, PLoS pathogens.

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

Hasan Ahmed, Hongmei Gao, Jaranit Kaewkungwal, 2012, The Journal of infectious diseases.

Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Raphael Gottardo, Hongmei Gao, Bette T. Korber, 2013, Journal of Virology.

LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays

Hongmei Gao, Josh Eckels, David C Montefiori, 2011, BMC Immunology.

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies

Tongqing Zhou, Hongmei Gao, David C Montefiori, 2018, PLoS pathogens.

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

T. Kepler, M. Borgnia, B. Korber, 2019, PLoS pathogens.

Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.

Xuesong Yu, Gary Li, Hongmei Gao, 2012, Journal of immunological methods.

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

D. Montefiori, R. Gottardo, G. Ferrari, 2021, Vaccine.

Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.

D. Montefiori, Y. Ruan, K. Hong, 2012, The Journal of general virology.

Correction for Hraber et al., “Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments”

B. Korber, P. Hraber, J. Mascola, 2018, Journal of Virology.

Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments

B. Korber, P. Hraber, J. Mascola, 2017, Journal of Virology.

International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials

Hongmei Gao, Marcella Sarzotti-Kelsoe, David C. Montefiori, 2012, PloS one.

Focusing antibody responses to the fusion peptide in rhesus macaques

D. Irvine, D. Burton, D. Montefiori, 2023, bioRxiv.